Letters Drug combination for obesity

First do no harm with anti-obesity and other drugs

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3026 (Published 28 May 2013) Cite this as: BMJ 2013;346:f3026
  1. Bruno Toussaint, editorial director1
  1. 1Prescrire, Paris, Cedex 11, France
  1. contact{at}prescrire.org

On the issue of obesity,1 we welcome the decision by the European Medicines Agency to refuse marketing authorisation for the fixed dose combination of topiramate (an antiepileptic) and phentermine (an appetite suppressant amphetamine).2

The loss of a few kilograms cannot justify …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe